Peptide bioavailability has been significantly enhanced in recent years, evidenced by Pfizer developing an optimized formulation for its oral GLP-1 drug danuglipron, AbbVie buying...
The T-cell engager (TCE) field has seen unprecedented growth, with eight approvals in the past two years—most recently tarlatamab—reinforcing its potential as a dominant...
Lipid-based nanoparticles are evolving-faster, safer and more precise than ever. With traditional LNPs struggling to reach tissues beyond the liver, the industry is doubling down...
Returning for the 2nd year, the Computational RNA Design and Delivery Summit is the only industry-led meeting of its kind dedicated to congregating the most forward thinking biotechs...
Join industry leaders to explore the evolving role of Risk Evaluation and Mitigation Strategies (REMS) in drug safety. Participate in in-depth sessions and case studies on patient...
Join the 6th Annual Promotional Review Summit (Oct 13-14, 2025, Philadelphia) to explore compliance, workflow efficiency, and innovation in pharma, biotech, and medical device...
